Advertisement

Resverlogix Corp. RVX.TO

Set alert

Price alert · RVX.TO

All alert types
0.08 CAD 0.00 0.00%

As of Nov 2, 3:05 PM ET

0.075 Day range 0.075
0.075 52-week range 0.15
YTD
-25.00%
1 year
-25.00%
Open
0.075
Prev close
0.075
Mkt cap
25.82M
Vol
3.00K
Avg vol
24.21K
EPS
-0.04
P/E
0.00
Div yield
0.00%
More statistics
Low
0.075
High
0.075
Forward P/E
-0.25
Beta
0.00
Short ratio
0.61
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.0632
200-d avg
0.0623
1y target
0.00

2Y chart

Chart tools
Interval

Signals (133)
NameDateAgo
MACD: Sell SignalOct 26, 20261 week ago
MACD: Buy SignalOct 23, 20261 week ago
RSI: OversoldOct 16, 20262 weeks ago
MACD: Sell SignalOct 5, 20264 weeks ago
SMA: BearishSep 30, 20261 month ago
SMA: BearishSep 28, 20261 month ago
SMA: BullishSep 25, 20261 month ago
SMA: BullishSep 25, 20261 month ago
MACD: Buy SignalSep 25, 20261 month ago
RSI: OverboughtSep 25, 20261 month ago
SMA: BearishAug 26, 20262 months ago
MACD: Sell SignalAug 26, 20262 months ago
SMA: BullishAug 25, 20262 months ago
MACD: Buy SignalAug 25, 20262 months ago
MACD: Sell SignalAug 18, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BullishAug 13, 20262 months ago
MACD: Buy SignalAug 13, 20262 months ago
SMA: BearishAug 5, 20262 months ago
MACD: Sell SignalAug 5, 20262 months ago
SMA: BullishAug 4, 20263 months ago
MACD: Buy SignalAug 4, 20263 months ago
MACD: Sell SignalJul 30, 20263 months ago
SMA: BearishJul 28, 20263 months ago
SMA: BullishJul 24, 20263 months ago
SMA: BearishJul 23, 20263 months ago
SMA: BullishJul 22, 20263 months ago
SMA: BearishJul 14, 20263 months ago
SMA: BullishJul 13, 20263 months ago
SMA: BullishJul 7, 20263 months ago
MACD: Buy SignalJul 7, 20263 months ago
SMA: BearishJun 30, 20264 months ago
SMA: BullishJun 29, 20264 months ago
MACD: Sell SignalJun 19, 20264 months ago
RSI: OversoldJun 19, 20264 months ago
MACD: Buy SignalMay 11, 20265 months ago
SMA: BearishApr 28, 20266 months ago
SMA: BullishApr 27, 20266 months ago
SMA: BearishApr 22, 20266 months ago
MACD: Sell SignalApr 22, 20266 months ago
MACD: Buy SignalApr 21, 20266 months ago
SMA: BullishApr 20, 20266 months ago
SMA: BearishApr 17, 20266 months ago
MACD: Sell SignalApr 17, 20266 months ago
MACD: Buy SignalApr 14, 20266 months ago
SMA: BullishApr 8, 20266 months ago
SMA: BearishApr 7, 20266 months ago
SMA: BullishApr 2, 20267 months ago
SMA: BearishApr 1, 20267 months ago
SMA: BearishMar 27, 20267 months ago
SMA: BullishMar 26, 20267 months ago
MACD: Sell SignalMar 16, 20267 months ago
RSI: OverboughtMar 5, 20268 months ago
MACD: Buy SignalFeb 24, 20268 months ago
SMA: BullishFeb 20, 20268 months ago
SMA: BearishFeb 12, 20268 months ago
MACD: Sell SignalFeb 12, 20268 months ago
RSI: OverboughtFeb 9, 20268 months ago
SMA: BullishJan 30, 20269 months ago
SMA: BearishJan 28, 20269 months ago
SMA: BullishJan 26, 20269 months ago
MACD: Buy SignalJan 13, 20269 months ago
SMA: BearishDec 19, 202510 months ago
MACD: Sell SignalDec 11, 202510 months ago
RSI: OverboughtDec 2, 202511 months ago
SMA: BullishNov 26, 202511 months ago
SMA: BearishNov 25, 202511 months ago
RSI: OverboughtNov 21, 202511 months ago
SMA: BullishNov 19, 202511 months ago
MACD: Buy SignalNov 13, 202511 months ago
SMA: BearishOct 22, 20251 year ago
MACD: Sell SignalOct 22, 20251 year ago
SMA: BullishOct 3, 20251 year ago
MACD: Buy SignalSep 29, 20251 year ago
MACD: Sell SignalSep 25, 20251 year ago
MACD: Buy SignalSep 24, 20251 year ago
MACD: Sell SignalSep 22, 20251 year ago
MACD: Buy SignalSep 18, 20251 year ago
SMA: BearishSep 8, 20251 year ago
MACD: Sell SignalJul 30, 20251 year ago
RSI: OverboughtJul 14, 20251 year ago
SMA: BullishJul 2, 20251 year ago
MACD: Buy SignalJul 2, 20251 year ago
SMA: BearishJun 12, 20251 year ago
MACD: Sell SignalJun 12, 20251 year ago
MACD: Buy SignalJun 11, 20251 year ago
SMA: BullishJun 9, 20251 year ago
SMA: BearishJun 5, 20251 year ago
MACD: Sell SignalJun 5, 20251 year ago
MACD: Buy SignalMay 26, 20251 year ago
SMA: BullishMay 23, 20251 year ago
MACD: Sell SignalMay 15, 20251 year ago
SMA: BearishMay 14, 20251 year ago
SMA: BullishMay 5, 20251 year ago
SMA: BearishMay 1, 20251 year ago
SMA: BullishApr 30, 20251 year ago
MACD: Buy SignalApr 30, 20251 year ago
SMA: BearishApr 17, 20251 year ago
SMA: BullishApr 16, 20251 year ago
SMA: BearishApr 10, 20251 year ago
MACD: Sell SignalApr 10, 20251 year ago
SMA: BullishApr 4, 20251 year ago
MACD: Buy SignalApr 4, 20251 year ago
SMA: BearishApr 3, 20251 year ago
MACD: Sell SignalApr 3, 20251 year ago
MACD: Buy SignalApr 2, 20251 year ago
SMA: BullishApr 1, 20251 year ago
SMA: BearishMar 31, 20251 year ago
SMA: BullishMar 28, 20251 year ago
MACD: Sell SignalMar 27, 20251 year ago
MACD: Buy SignalMar 25, 20251 year ago
MACD: Sell SignalMar 24, 20251 year ago
MACD: Buy SignalMar 7, 20251 year ago
MACD: Sell SignalMar 3, 20251 year ago
MACD: Buy SignalFeb 27, 20251 year ago
MACD: Sell SignalFeb 25, 20251 year ago
MACD: Buy SignalFeb 14, 20251 year ago
SMA: BearishJan 31, 20251 year ago
MACD: Sell SignalJan 31, 20251 year ago
SMA: BullishJan 30, 20251 year ago
MACD: Buy SignalJan 30, 20251 year ago
SMA: BearishJan 29, 20251 year ago
SMA: BullishJan 28, 20251 year ago
SMA: BearishJan 24, 20251 year ago
SMA: BullishJan 23, 20251 year ago
MACD: Sell SignalJan 21, 20251 year ago
MACD: Buy SignalJan 15, 20251 year ago
MACD: Sell SignalJan 10, 20251 year ago
MACD: Buy SignalJan 6, 20251 year ago
MACD: Sell SignalJan 2, 20251 year ago
MACD: Buy SignalDec 30, 20241 year ago
MACD: Sell SignalDec 27, 20241 year ago
RSI: OversoldDec 27, 20241 year ago

Key statistics

Market cap
15.44M
Enterprise value
80.30M
Trailing P/E
0.00
Forward P/E
-0.25
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
-0.06
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
12.29M
Total cash
43.00K
Total debt
65.25M
Return on equity
0.00%
Shares outstanding
280.65M
Short % of float
0.00%
50-day average
0.0632
200-day average
0.0623

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

About Resverlogix Corp.

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. The company's lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein cholesterol, recent acute coronary syndrome, and post COVID-19 conditions. It has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company is headquartered in Calgary, Canada.

Sector
Healthcare
Industry
Biotechnology
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on RVX.TO — it syncs with the Stock Master app.

Institution ownership

RVX.TO institution ownership
Holder% heldSharesValueReported
Captrust Financial Advisors0.00%4,000219Jun 29, 2022
Advertisement